183 related articles for article (PubMed ID: 37907747)
1. Single-cell characterization of macrophages in uveal melanoma uncovers transcriptionally heterogeneous subsets conferring poor prognosis and aggressive behavior.
Li K; Sun L; Wang Y; Cen Y; Zhao J; Liao Q; Wu W; Sun J; Zhou M
Exp Mol Med; 2023 Nov; 55(11):2433-2444. PubMed ID: 37907747
[TBL] [Abstract][Full Text] [Related]
2. Integration of Bulk RNA Sequencing and Single-Cell RNA Sequencing to Reveal Uveal Melanoma Tumor Heterogeneity and Cells Related to Survival.
Gao G; Deng A; Liang S; Liu S; Fu X; Zhao X; Yu Z
Front Immunol; 2022; 13():898925. PubMed ID: 35865532
[TBL] [Abstract][Full Text] [Related]
3. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
[TBL] [Abstract][Full Text] [Related]
4. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.
Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE
Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma.
Amaro A; Parodi F; Diedrich K; Angelini G; Götz C; Viaggi S; Maric I; Coviello D; Pistillo MP; Morabito A; Mandalà M; Ghiorzo P; Visconti P; Gualco M; Anselmi L; Puzone R; Lanza F; Mosci C; Raggi F; Bosco MC; Varesio L; Zeschnigk M; Spano L; Queirolo P; Pfeffer U
JAMA Ophthalmol; 2016 Oct; 134(10):1125-1133. PubMed ID: 27532663
[TBL] [Abstract][Full Text] [Related]
6. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
8. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
9. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
[TBL] [Abstract][Full Text] [Related]
10. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma.
Jiang Z; Liu F
Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142
[TBL] [Abstract][Full Text] [Related]
11. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
[TBL] [Abstract][Full Text] [Related]
12. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.
Weidmann C; Bérubé J; Piquet L; de la Fouchardière A; Landreville S
Clin Exp Metastasis; 2018 Mar; 35(3):123-134. PubMed ID: 29696577
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis reveals the dysfunction of signaling pathways in uveal melanoma.
Sun S; Guo B; Xu L; Shi R
BMC Cancer; 2022 Jul; 22(1):734. PubMed ID: 35790930
[TBL] [Abstract][Full Text] [Related]
14. Identification of heterogeneity and prognostic key genes associated with uveal melanoma using single-cell RNA-sequencing technology.
Sun S; Shi R; Xu L; Sun F
Melanoma Res; 2022 Feb; 32(1):18-26. PubMed ID: 34879031
[TBL] [Abstract][Full Text] [Related]
15. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.
Bronkhorst IH; Vu TH; Jordanova ES; Luyten GP; Burg SH; Jager MJ
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5370-8. PubMed ID: 22743317
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma.
Lei S; Zhang Y
BMC Med Genomics; 2022 Mar; 15(1):61. PubMed ID: 35300699
[TBL] [Abstract][Full Text] [Related]
17. Monoacylglycerol lipase regulates macrophage polarization and cancer progression in uveal melanoma and pan-cancer.
Tan Y; Pan J; Deng Z; Chen T; Xia J; Liu Z; Zou C; Qin B
Front Immunol; 2023; 14():1161960. PubMed ID: 37033945
[TBL] [Abstract][Full Text] [Related]
18. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Lei S; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.
Lachota M; Lennikov A; Malmberg KJ; Zagozdzon R
J Immunol Res; 2021; 2021():9920234. PubMed ID: 34195299
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
